Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16399967 | 0.77 | CYP1A2 (0.50) | CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL16399969 | 0.77 | CYP1A2 (0.50) | CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL19914300 | 0.74 | CYP1A2 (0.46) | CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL13172381 | 0.73 | PDK2 (0.45) | CYP2C19LMNAALDH1A1HPGD | |
| SCHEMBL15356031 | 0.73 | PDK2 (0.42) | CYP2C19LMNAALDH1A1HPGD | |
| SCHEMBL21163172 | 0.72 | CYP2C19 (0.45) | CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL16399731 | 0.72 | CYP1A2 (0.46) | CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL16399734 | 0.72 | CYP1A2 (0.46) | CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL17916129 | 0.72 | PLAT (0.43) | KMT2AMEN1 | |
| SCHEMBL12783412 | 0.72 | PDK2 (0.38) | CYP2C19KMT2AALDH1A1MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210040118-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | BETTA PHARMACEUTICALS CO., LTD (CN) | 2021-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210040118-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | IL2, IL5, TSLP | CYP1A2 1133/4885CYP2C9 2964/4885CYP2C19 2147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.